5The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke.N Engl J Med,1995,333:1581-1588.
6The ECASS study Group.Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke:the European cooperative acute stroke study (ECASS).JAMA,1995,274:1017-1025.
7Antithrombotic and thrombolytic therapy for ischemic stroke:the seventh ACCP conference on antithrombotic and thrombolytic therapy.Chest,2004,126:483-512.
8Hacke W,Bluhmki E,Steiner T,et al.Dichotomized efficacy end global end-point analysis applied to the ECASS Ⅰ.Stroke,1998,29:2073-2075.
9Berger C,Fiorelli M,Steiner T,et al.Hemorrhagic transformation of ischemic brain tissue:asymptomatic or symptomatic? Stroke,2001,32:1330-1335.
10Brandt T,von Kummer R,Muller-Kuppers M,et al.Thrombolytic therapy of acute basilar artery occlusion.Variables affecting recanalization and outcome.Stroke,1996,27:875-881.
8Groger M, Lebesgue D. Release of bradykinin and expression of kinin B- receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemla in mice [ J ]. J Cereb Blood Flow Metab,2005,25 (9) :978 - 989.
